Comparison of Efficacy of Transdermal Fentanyl Patch in Treatment of Chronic Soft Tissue Cancer Pain With Placebo in A Double-Blind Randomized Clinical Trial

[1]  L. Manchikanti,et al.  Effectiveness of opioids in the treatment of chronic non-cancer pain. , 2008, Pain physician.

[2]  Barbara Schaefer Bitros.  Advocating for Management of Cancer Pain , 2007, The Journal of the American Osteopathic Association.

[3]  L. Eberhart.  The safety and tolerability of the fentanyl HCl iontophoretic transdermal system: an alternative to currently available analgesic modalities. , 2007, Journal of opioid management.

[4]  B. Demirkan,et al.  Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial. , 2007, European journal of cancer care.

[5]  R. Williams,et al.  Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Simmonds Ma.  Pharmacotherapeutic management of cancer pain: current practice. , 1997 .

[7]  B. Napolitano,et al.  Unmet analgesic needs in cancer patients. , 1995, Journal of pain and symptom management.

[8]  S. Grond,et al.  Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. , 1994, Journal of pain and symptom management.

[9]  M. Fallon,et al.  Transdermal fentanyl in cancer pain , 1994 .

[10]  R. Payne.  Transdermal fentanyl: suggested recommendations for clinical use. , 1992, Journal of pain and symptom management.

[11]  L. Strause,et al.  Transdermal fentanyl use in hospice home-care patients with chronic cancer pain. , 1992, Journal of pain and symptom management.